Stock screenerAll disclosures →
EDGAR →
ARWR
Conviction 100HealthcareScan · Thu, Jun 25, 2026ARWR$79.25-0.70%
ResistanceSupportVol 14Insider sell3
Vol MA14 2.24M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price79.25
Change-0.70%
Gap+0.81%
Rel volume5.79×
Avg volume2.03M
Avg $ vol157.45M
SMA 2076.41
SMA 5075.32
SMA 20059.16
Price vs 50+5.21%
Price vs 200+33.96%
MA stackbullish
50/200 cross—
Supertrendup · 70.96
RSI (14)56
MACD hist0.41
MACD crossbull · 5d
Stoch %K / %D65 / 67
ADX (14)17
+DI / −DI18 / 16
RSI divergenceBullish
MACD divergence—
ATR %+4.97%
ADR %5.12%
52w high82.00
52w low14.71
From 52w high-3.35%
Above 52w low+438.75%
New 52w highNo
SqueezeOff
Bollinger width18.12%
%B0.71
Donchian pos65.25%
Donchian high84.55
Donchian low69.30
AVWAP (52w high)80.90
vs AVWAP high-2.04%
AVWAP (52w low)53.29
vs AVWAP low+48.72%
OBV trendDown
Chaikin MF (20)-0.14
Today vs 20d5.79×
Avg vol (14d)2.24M
Avg vol (20d)2.03M
Avg $ vol (20d)157.45M
Market cap11.16B
RS 3m (vs SPY)+29.58%
RS 6m (vs SPY)+9.36%
RS line new highNo
Trend template8/8
Technical rank74.4
1 week-2.21%
1 month+0.72%
3 months+30.41%
6 months+14.86%
1 year+396.55%
YTD+16.91%
P/E-6844.22
P/B18.18
P/S13.46
P/FCF71.15
EPS-0.0100
Div yield—
ROE-0.27%
ROA-0.07%
Debt/Eq—
Current6.23
EV/EBITDA92.03
Gross margin—
Net margin-0.20%
Rev growth—
EPS growth99.73%
Price target89.25
Target upside12.62%
Analyst ratingBuy
Institutional97.90%
Ent. value11.09B
Revenue73.74M
Net income-132.73M
Gross profit—
Free cash flow156.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out140.86M
Employees711
ListedWed, Feb 1, 1995
Free float134.77M
Float %96.2%
Short interest12.39M
Days to cover8.3d
Short volume58.5%
Squeeze score71 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$1.16 · 7 est
Last EPS vs est−$0.93 vs −$1.18
Last surprise+21.2% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank74.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance83.40
Support69.56
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ARWR
No recent disclosed trades by Congress in ARWR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ARWR · 1 buy · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Cohen Matthew Gregory Director · Common Stock · 2026-06-15 | Grant | 11.88K | — | 2026-06-15 | 2026-06-17 |
Lu Hongbo Director · Common Stock · 2026-05-12 | Sell | 2.97K | $228K | 2026-05-12 | 2026-05-14 |
Hamilton James C Chief Medical Officer · Common Stock · 2026-04-23 | Sell | 10K | $750K | 2026-04-23 | 2026-04-24 |
Apel Daniel Joseph Chief Financial Officer · Common Stock · 2026-04-22 | Sell | 8.73K | $628K | 2026-04-22 | 2026-04-24 |
Apel Daniel Joseph Chief Financial Officer · Common Stock · 2026-04-22 | Sell | 1.16K | $82K | 2026-04-22 | 2026-04-24 |
Apel Daniel Joseph Chief Financial Officer · Common Stock · 2026-04-22 | Sell | 3.21K | $225K | 2026-04-22 | 2026-04-24 |
SEC filings
EDGAR filings in ARWR · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.